FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.8.2  |  FHIR Version n/a  User: [n/a]

768031005: Product containing bismuth biskalcitrate and metronidazole and tetracycline in oral dose form (medicinal product form)


Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2018. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
3708826014 Product containing bismuth biskalcitrate and metronidazole and tetracycline in oral dose form (medicinal product form) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
3708827017 Bismuth biskalcitrate- and metronidazole- and tetracycline-containing product in oral dose form en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core


2 descendants. Search Descendants:

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Product containing bismuth biskalcitrate and metronidazole and tetracycline in oral dose form (medicinal product form) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. Tetracycline (substance) true Inferred relationship Some 2
Product containing bismuth biskalcitrate and metronidazole and tetracycline in oral dose form (medicinal product form) Is a Metronidazole-containing product in oral dose form true Inferred relationship Some
Product containing bismuth biskalcitrate and metronidazole and tetracycline in oral dose form (medicinal product form) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. Bismuth biskalcitrate (substance) true Inferred relationship Some 3
Product containing bismuth biskalcitrate and metronidazole and tetracycline in oral dose form (medicinal product form) Is a Product containing tetracycline in oral dose form (medicinal product form) true Inferred relationship Some
Product containing bismuth biskalcitrate and metronidazole and tetracycline in oral dose form (medicinal product form) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. Metronidazole (substance) true Inferred relationship Some 1
Product containing bismuth biskalcitrate and metronidazole and tetracycline in oral dose form (medicinal product form) Is a Product containing bismuth biskalcitrate and metronidazole and tetracycline (medicinal product) true Inferred relationship Some
Product containing bismuth biskalcitrate and metronidazole and tetracycline in oral dose form (medicinal product form) Has manufactured dose form Oral dose form true Inferred relationship Some
Product containing bismuth biskalcitrate and metronidazole and tetracycline in oral dose form (medicinal product form) Plays role Antibacterial therapeutic role (role) false Inferred relationship Some

Inbound Relationships Type Active Source Characteristic Refinability Group
bismuthbiskalcitrat 140 mg + metronidazol 125 mg + tetracyclin 125 mg kapsel Is a False Product containing bismuth biskalcitrate and metronidazole and tetracycline in oral dose form (medicinal product form) Inferred relationship Some
Bismuth biskalcitrate and metronidazole and tetracycline only product in oral dose form Is a True Product containing bismuth biskalcitrate and metronidazole and tetracycline in oral dose form (medicinal product form) Inferred relationship Some

This concept is not in any reference sets

Back to Start